| Profit Statement | 2019 | 2020 | 2021 | |
| Sales | CZK mil | 239 | 271 | 368 |
| Gross Profit | CZK mil | 34.8 | 35.1 | 36.5 |
| EBITDA | CZK mil | 9.51 | 9.74 | 8.14 |
| EBIT | CZK mil | 7.67 | 8.05 | 6.59 |
| Financing Cost | CZK mil | 0.796 | 0.234 | 0.485 |
| Pre-Tax Profit | CZK mil | 6.88 | 7.00 | 5.39 |
| Net Profit | CZK mil | 5.51 | 5.89 | 3.81 |
| Balance Sheet | 2019 | 2020 | 2021 | |
| Total Assets | CZK mil | 57.1 | 81.7 | 111 |
| Non-Current Assets | CZK mil | 7.55 | 6.82 | 6.10 |
| Current Assets | CZK mil | 48.9 | 74.2 | 105 |
| Working Capital | CZK mil | 8.71 | 22.7 | -10.9 |
| Shareholders' Equity | CZK mil | 12.9 | 18.8 | 22.6 |
| Liabilities | CZK mil | 44.2 | 62.9 | 88.8 |
| Total Debt | CZK mil | 0 | 15.0 | 15.0 |
| Net Debt | CZK mil | -3.92 | 6.20 | -7.64 |
| Ratios | 2019 | 2020 | 2021 | |
| ROE | % | ... | 37.1 | 18.4 |
| ROCE | % | ... | 25.7 | 30.8 |
| Gross Margin | % | 14.6 | 13.0 | 9.90 |
| EBITDA Margin | % | 3.99 | 3.60 | 2.21 |
| EBIT Margin | % | 3.21 | 2.97 | 1.79 |
| Net Margin | % | 2.31 | 2.18 | 1.03 |
| Net Debt/EBITDA | -0.412 | 0.636 | -0.938 | |
| Net Debt/Equity | % | -30.3 | 32.9 | -33.7 |
| Cost of Financing | % | ... | 3.12 | 3.23 |
| Cash Flow | 2019 | 2020 | 2021 | |
| Total Cash From Operations | CZK mil | ... | 5.79 | 14.6 |
| Total Cash From Investing | CZK mil | ... | -0.904 | -0.777 |
| Total Cash From Financing | CZK mil | ... | 0 | 0 |
| Net Change In Cash | CZK mil | ... | 3.92 | 8.81 |
| Cash Conversion Cycle | days | 9.55 | 27.4 | -15.0 |
| Cash Earnings | CZK mil | 7.35 | 7.58 | 5.36 |
| Free Cash Flow | CZK mil | ... | 4.89 | 13.8 |
Get all company financials in excel:
| overview | Unit | 2019 | 2020 | 2021 |
| income statement | ||||
| Sales | CZK mil | 239 | ||
| Gross Profit | CZK mil | 34.8 | ||
| EBIT | CZK mil | 7.67 | ||
| Net Profit | CZK mil | 5.51 | ||
| ROE | % | ... | ||
| EBIT Margin | % | 3.21 | ||
| Net Margin | % | 2.31 | ||
| Employees | ... | |||
| balance sheet | ||||
| Total Assets | CZK mil | 57.1 | ||
| Non-Current Assets | CZK mil | 7.55 | ||
| Current Assets | CZK mil | 48.9 | ||
| Shareholders' Equity | CZK mil | 12.9 | ||
| Liabilities | CZK mil | 44.2 | ||
| Non-Current Liabilities | CZK mil | 0 | ||
| Current Liabilities | CZK mil | 44.1 | ||
| Net Debt/EBITDA | -0.412 | |||
| Net Debt/Equity | % | -30.3 | ||
| Cost of Financing | % | ... | ||
| cash flow | ||||
| Total Cash From Operations | CZK mil | ... | ||
| Total Cash From Investing | CZK mil | ... | ||
| Total Cash From Financing | CZK mil | ... | ||
| Net Change In Cash | CZK mil | ... |
| income statement | Unit | 2019 | 2020 | 2021 |
| income statement | ||||
| Sales | CZK mil | 239 | ||
| Cost of Goods & Services | CZK mil | 204 | ||
| Gross Profit | CZK mil | 34.8 | ||
| Staff Cost | CZK mil | 33.9 | ||
| Other Operating Cost (Income) | CZK mil | -0.957 | ||
| EBITDA | CZK mil | 9.51 | ||
| Depreciation | CZK mil | 1.84 | ||
| EBIT | CZK mil | 7.67 | ||
| Net Financing Cost | CZK mil | 0.790 | ||
| Financing Cost | CZK mil | 0.796 | ||
| Financing Income | CZK mil | 0.006 | ||
| Extraordinary Cost | CZK mil | 0 | ||
| Pre-Tax Profit | CZK mil | 6.88 | ||
| Tax | CZK mil | 1.37 | ||
| Minorities | CZK mil | 0 | ||
| Net Profit | CZK mil | 5.51 | ||
| Net Profit Avail. to Common | CZK mil | 5.51 | ||
| growth rates | ||||
| Total Revenue Growth | % | ... | ||
| Staff Cost Growth | % | ... | ||
| EBITDA Growth | % | ... | ||
| EBIT Growth | % | ... | ||
| Pre-Tax Profit Growth | % | ... | ||
| Net Profit Growth | % | ... | ||
| ratios | ||||
| ROE | % | ... | ||
| ROA | % | ... | ||
| ROCE | % | ... | ||
| Gross Margin | % | 14.6 | ||
| EBITDA Margin | % | 3.99 | ||
| EBIT Margin | % | 3.21 | ||
| Net Margin | % | 2.31 | ||
| Cost of Financing | % | ... | ||
| Net Debt/EBITDA | -0.412 |
| balance sheet | Unit | 2019 | 2020 | 2021 |
| balance sheet | ||||
| Cash & Cash Equivalents | CZK mil | 3.92 | ||
| Receivables | CZK mil | 23.2 | ||
| Inventories | CZK mil | 21.8 | ||
| Current Assets | CZK mil | 48.9 | ||
| Property, Plant & Equipment | CZK mil | 7.55 | ||
| LT Investments & Receivables | CZK mil | 0 | ||
| Intangible Assets | CZK mil | 0 | ||
| Goodwill | CZK mil | 0 | ||
| Non-Current Assets | CZK mil | 7.55 | ||
| Total Assets | CZK mil | 57.1 | ||
| Trade Payables | CZK mil | 36.3 | ||
| Short-Term Debt | CZK mil | 0 | ||
| Other ST Liabilities | CZK mil | 7.86 | ||
| Current Liabilities | CZK mil | 44.1 | ||
| Long-Term Debt | CZK mil | 0 | ||
| Other LT Liabilities | CZK mil | 0 | ||
| Non-Current Liabilities | CZK mil | 0 | ||
| Liabilities | CZK mil | 44.2 | ||
| Equity Before Minority Interest | CZK mil | 12.9 | ||
| Minority Interest | CZK mil | 0 | ||
| Equity | CZK mil | 12.9 | ||
| growth rates | ||||
| Total Asset Growth | % | ... | ||
| Shareholders' Equity Growth | % | ... | ||
| Net Debt Growth | % | ... | ||
| Total Debt Growth | % | ... | ... | |
| ratios | ||||
| Total Debt | CZK mil | 0 | ||
| Net Debt | CZK mil | -3.92 | ||
| Working Capital | CZK mil | 8.71 | ||
| Capital Employed | CZK mil | 16.3 | ||
| Net Debt/Equity | % | -30.3 | ||
| Current Ratio | 1.11 | |||
| Quick Ratio | 0.614 |
| cash flow | Unit | 2019 | 2020 | 2021 |
| cash flow | ||||
| Net Profit | CZK mil | 5.51 | ||
| Depreciation | CZK mil | 1.84 | ||
| Non-Cash Items | CZK mil | ... | ||
| Change in Working Capital | CZK mil | ... | ||
| Total Cash From Operations | CZK mil | ... | ||
| Capital Expenditures | CZK mil | ... | ||
| Other Investing Activities | CZK mil | ... | ||
| Total Cash From Investing | CZK mil | ... | ||
| Dividends Paid | CZK mil | ... | ||
| Issuance Of Shares | CZK mil | ... | ||
| Issuance Of Debt | CZK mil | ... | ||
| Total Cash From Financing | CZK mil | ... | ||
| Net Change In Cash | CZK mil | ... | ||
| ratios | ||||
| Days Sales Outstanding | days | 35.4 | ||
| Days Sales Of Inventory | days | 39.1 | ||
| Days Payable Outstanding | days | 65.0 | ||
| Cash Conversion Cycle | days | 9.55 | ||
| Cash Earnings | CZK mil | 7.35 | ||
| Free Cash Flow | CZK mil | ... | ||
| Capital Expenditures (As % of Sales) | % | ... |
| other ratios | Unit | 2019 | 2020 | 2021 |
| Employees | ... | |||
| Cost Per Employee | USD per month | ... | ||
| Cost Per Employee (Local Currency) | CZK per month | ... | ||
| Material & Energy (As % of Sales) | % | 78.7 | ||
| Services (As % of Sales) | % | 6.70 | ||
| Marketing Cost (As % of Sales) | % | ... | ||
| Staff Cost (As % of Sales) | % | 14.2 | ||
| Effective Tax Rate | % | 19.9 | ||
| Branches | ... | ... |
Get all company financials in excel:
Chytra Lekarna has been growing its sales by a year on average in the last 5 years. EBITDA has grown by 0% during that time to total of CZK 8.14 mil in 2021, or 2.21% of sales. That’s compared to 3.26% average margin seen in last five years.
The company netted CZK 3.81 mil in 2021 implying ROE of 18.4% and ROCE of 30.8%. Again, the average figures were 27.7% and 28.3%, respectively when looking at the previous 5 years.
Chytra Lekarna’s net debt amounted to CZK -7.64 mil at the end of 2021, or -33.7% of equity. When compared to EBITDA, net debt was -0.938x, down when compared to average of -0.238x seen in the last 5 years.
Helgi Library 
